Citi Pharma gets FDA nod to start exporting nutraceuticals to the United States
The pharmaceutical ingredients manufacturer enters the consumer-facing market in the US with a product the US regulator classifies as food, and not drugs
IPO proceeds in 2018 plunged by 49% to Rs4.8 billion
AGP Pharmaceutical, one of the largest companies in the country’s pharmaceutical sector via its offer for sale (OFS) collected 65% of total raised capital during 2018
DRAP’s survey on drug price hikes irks pharmaceutical manufacturers
Third-party survey initiated in response to public outcry over rising medicine prices after deregulation of non-essential drugs; PPMA voices concerns over lack of industry stakeholder involvement
Lucky Core seals deal for Pfizer’s Karachi plant, pharma products
Asset Purchase Agreements signed, acquisition includes products such as Ansaid, Ponstan, Ponstan Forte, Basoquin, Deltacortril, Lysovit, Corex-D, and Mycitracin.Â
LCCI demands DRAP to form a liaison committee
LAHORE: The Lahore Chamber of Commerce and Industry (LCCI) has demanded from the Drug Regulatory Authority of Pakistan (DRAP) to form a liaison committee...
Citi Pharma enters into supply agreement with India’s Murli Krishna PharmaÂ
Murli Krishna Pharma will supply high-quality Active Pharmaceutical Ingredients (APIs) and products exclusively to Citi Pharma in Pakistan
BF Biosciences expands production, launches diabetes treatment, secures listing approval
Company receives approval for brownfield expansion and launches Sematide, a new diabetes treatment, while listing application is greenlit by SECP and PSX
OBS Pakistan amalgamates AGP with AitkenStuart
It is pertinent to mention that rumours had been circulating that OBS Pakistan was going through major restructuring and this acquisition by Searle comes as a surprise for the market.
BF Biosciences plans to raise Rs 1.37 billion through IPOÂ
IPO will consist of 25 million ordinary shares with floor price of PKR 55 per share
Sales tax hike to 18% expected to raise medicine prices
Sales tax is also imposed on diagnostic kits/equipment across various specialties, including cardiology, neurology, oncology, and urologyÂ
Highnoon Laboratories partners with Bangladesh-based Beximco Pharmaceuticals for strategic collaboration
Both firms sign MoU to distribute and market specialised pharmaceutical products in Pakistan, focusing on key therapeutic areas
Pharmaceuticals in Pakistan: extracting whatever they can from the pie
Can the pharmaceutical sector ever be reformed? Kabeer Dawani and Asad Sayeed take a look at the sector’s pitfalls, and ways forward.
Citi Pharma ventures into direct marketing sector
Company aims to improve medicine accessibility and expand globally
French companies invited to invest in food industry, pharmaceutical sector
ISLAMABAD: Minister of State for Finance Rana Muhammad Afzal Khan on Friday invited investment by French companies in the food industry, pharmaceuticals, skill development...
Pakistan’s retail pharma sector surpasses Rs1.049 trillion in salesÂ
Data from IQVIA reveals steep price hikes drive growth as medicine consumption shows minimal increase, raising concerns over affordability
